Skip to main content
Skip to navigation
Vaccine and Infectious Disease Organization
Menu
Search the USask
Search
About
About
History
Mission, Vision, Values
Safety & Security
Facilities
Community Liaison Committee
Frequently Asked Questions
Contact Us
Annual Reports
Donor Information
Team
Board of Directors
Senior Leadership
Science Management
Principal Scientists and Veterinarians
Contract Research
Scientific Advisory Board
Access Committee
Research
Research Projects
Veterinary Services
Publications
Patents
One Health
Contract Services
All Contract Services
Contract Development and Manufacturing
Contract Research
Careers
Current Opportunities
Working at VIDO
Benefits at VIDO
Training
Visiting Scientists
News
Donate Now
Index
Saskatchewan Blue Cross invests $150K to help establish USask’s VIDO as Canada’s Centre for Pandemic Research
Infectious disease research bolstered by Hospitals of Regina Foundation
VIDO gift has far-reaching impacts
Saskatoon hospital foundations offer support to USask’s VIDO
News Archive - 2021
VIDO research provides insight into the immune response and possible long-term health impacts associated with COVID-19
VIDO gains provincial support towards becoming a ‘Centre for Pandemic Research’
USask’s VIDO begins COVID-19 vaccine clinical trials at CCfV
USask’s VIDO announces positive Phase 1 results for COVAC-2
Saskatoon couple donates $1 million to VIDO to enhance ground-breaking vaccine research
Saskatchewan Blue Cross invests $150K to help establish USask’s VIDO as Canada’s Centre for Pandemic Research
New funding will help predict SARS-CoV-2 variants and protect vulnerable populations
Infectious disease research bolstered by Hospitals of Regina Foundation
Federal budget supports USask’s VIDO with $59.2M
CEPI awards USask’s VIDO $6M for vaccine development
Canada’s Global Nexus and VIDO join forces to combat COVID–19
A new year, and a new look
